1. Home
  2. KRYS vs AGO Comparison

KRYS vs AGO Comparison

Compare KRYS & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • AGO
  • Stock Information
  • Founded
  • KRYS 2015
  • AGO 2003
  • Country
  • KRYS United States
  • AGO Bermuda
  • Employees
  • KRYS N/A
  • AGO N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • AGO Property-Casualty Insurers
  • Sector
  • KRYS Health Care
  • AGO Finance
  • Exchange
  • KRYS Nasdaq
  • AGO Nasdaq
  • Market Cap
  • KRYS 3.8B
  • AGO 4.2B
  • IPO Year
  • KRYS 2017
  • AGO 2004
  • Fundamental
  • Price
  • KRYS $143.08
  • AGO $85.50
  • Analyst Decision
  • KRYS Strong Buy
  • AGO Buy
  • Analyst Count
  • KRYS 9
  • AGO 3
  • Target Price
  • KRYS $208.78
  • AGO $103.33
  • AVG Volume (30 Days)
  • KRYS 374.0K
  • AGO 356.3K
  • Earning Date
  • KRYS 08-04-2025
  • AGO 08-06-2025
  • Dividend Yield
  • KRYS N/A
  • AGO 1.59%
  • EPS Growth
  • KRYS 109.01
  • AGO N/A
  • EPS
  • KRYS 4.16
  • AGO 8.34
  • Revenue
  • KRYS $333,448,000.00
  • AGO $884,000,000.00
  • Revenue This Year
  • KRYS $44.05
  • AGO N/A
  • Revenue Next Year
  • KRYS $46.15
  • AGO N/A
  • P/E Ratio
  • KRYS $34.43
  • AGO $10.25
  • Revenue Growth
  • KRYS 247.53
  • AGO N/A
  • 52 Week Low
  • KRYS $122.80
  • AGO $72.57
  • 52 Week High
  • KRYS $219.34
  • AGO $96.50
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 57.50
  • AGO 48.55
  • Support Level
  • KRYS $135.86
  • AGO $84.76
  • Resistance Level
  • KRYS $143.44
  • AGO $88.01
  • Average True Range (ATR)
  • KRYS 5.15
  • AGO 1.48
  • MACD
  • KRYS 1.07
  • AGO 0.00
  • Stochastic Oscillator
  • KRYS 80.33
  • AGO 42.56

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About AGO Assured Guaranty Ltd.

Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.

Share on Social Networks: